Last reviewed · How we verify
Children's Mucinex® Grape Flavor
Children's Mucinex® Grape Flavor is a Small molecule drug developed by Reckitt Benckiser LLC. It is currently in Phase 1 development.
At a glance
| Generic name | Children's Mucinex® Grape Flavor |
|---|---|
| Sponsor | Reckitt Benckiser LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Children's Mucinex® Grape Flavor CI brief — competitive landscape report
- Children's Mucinex® Grape Flavor updates RSS · CI watch RSS
- Reckitt Benckiser LLC portfolio CI
Frequently asked questions about Children's Mucinex® Grape Flavor
What is Children's Mucinex® Grape Flavor?
Children's Mucinex® Grape Flavor is a Small molecule drug developed by Reckitt Benckiser LLC.
Who makes Children's Mucinex® Grape Flavor?
Children's Mucinex® Grape Flavor is developed by Reckitt Benckiser LLC (see full Reckitt Benckiser LLC pipeline at /company/reckitt-benckiser-llc).
What development phase is Children's Mucinex® Grape Flavor in?
Children's Mucinex® Grape Flavor is in Phase 1.